Histone posttranslational modifications have long been recognized to be crucial epigenetic regulators that mediate health, disease and survival. My endpoint goal will be to incorporate the latest in data acquisition and analysis into the toxicoepigenetic mass spectrometry-based assay that is currently under development at the Lab of Pharmaceutical Biotechnology, in order to improve the reliability of the assay report.